Aboleris Holdco
De berekende faillissementskans van Aboleris Holdco over 12 maanden bedraagt 1,0% (laag). De jaarrekening over 2024 toont een eigen vermogen van €12,60M en een nettoresultaat van €-7,78M. De solvabiliteit is beter dan 95% van 42 sectorgenoten (boekjaar 2024). Het bedrijf is actief sinds 2023 en het Belgisch Staatsblad bevat geen insolventie- of waarschuwingssignalen.
| Eigen vermogen | €12,60M |
| Netto resultaat | €-7,78M |
| Beter dan sector | 95% |
| Actief | 3 jaar |
Sterk profiel, met solvabiliteit als uitschieter.
Alle 5 assen zijn berekend uit gegevens die Checked heeft ingelezen.
Statistische inschatting op basis van openbare bronnen, geen kredietadvies of vaststelling. Hoe berekenen we dit?
De volledige opbouw van de score, de scoregeschiedenis per boekjaar en de indicatieve kredietlimiet ontgrendel je met Plus.
Bekijk plannen →| Kengetal | Dit bedrijf | Sectormediaan | Positie in de sector |
|---|---|---|---|
| Solvabiliteit | 95,0% | 53,6% | |
| Nettoresultaat | €-7,78M | €-16k | |
| Eigen vermogen | €12,60M | €644k | |
| Bruto bedrijfsmarge | €-7,81M | €7k | |
| Totaal activa | €13,27M | €1,71M |
| Boekjaar | 2024 |
|---|---|
| Neerlegging | volledig |
| Omzet | - |
| EBITDA | €-7,81M |
| Nettoresultaat | €-7,78M |
| Cashflow | €-7,77M |
| Personeelskosten | - |
| Belastingen op het resultaat | €3 |
| Dividenden | - |
| Totaal activa | €13,27M |
| Eigen vermogen | €12,60M |
| Schulden | €667k |
| waarvan ≤ 1 jaar | €667k |
| waarvan > 1 jaar | - |
| Werkkapitaal | €2,84M |
| Werknemers (VTE) | - |
| 2024 | |
|---|---|
| Current ratio | 5,25 |
| Quick ratio | 5,25 |
| Werkkapitaalratio | 21,4% |
| Solvabiliteit | 95,0% |
| Debt / equity | 0,05 |
| Langetermijnschuldgraad | - |
| Interest coverage | -181,55 |
| Bruto rentabiliteit | - |
| Netto rentabiliteit | - |
| ROA | -58,7% |
| ROE | -61,8% |
| EBITDA-marge | - |
| Klantenkrediet (DSO) | - |
| Leverancierskrediet (DPO) | - |
| Voorraadrotatie | - |
| Voorraaddagen (DSI) | - |
| Post | Code | 2024 |
|---|---|---|
| Balans, Activa | ||
| TOTAAL ACTIVA | 20/58 | €13,27M |
| Vaste activa | 21/28 | €9,76M |
| Oprichtingskosten | 20 | €0 |
| Immateriële vaste activa | 21 | €8k |
| Materiële vaste activa | 22/27 | €7k |
| Financiële vaste activa | 28 | €9,75M |
| Vlottende activa | 29/58 | €3,50M |
| Vorderingen op ten hoogste één jaar | 40/41 | €228k |
| Liquide middelen | 54/58 | €3,26M |
| Balans, Passiva | ||
| TOTAAL PASSIVA | 10/49 | €13,27M |
| Eigen vermogen | 10/15 | €12,60M |
| Inbreng / kapitaal | 10/11 | €23,49M |
| Overgedragen winst (verlies) | 14 | €-10,89M |
| Schulden | 17/49 | €667k |
| Schulden op ten hoogste één jaar | 42/48 | €667k |
| Handelsschulden op ten hoogste één jaar | 44 | €667k |
| Resultatenrekening | ||
| Bruto bedrijfsmarge | 9900 | €-7,81M |
| Bedrijfsresultaat | 9901 | €-7,82M |
| Financiële opbrengsten | 75 | €80k |
| Financiële kosten | 65 | €43k |
| Resultaat vóór belasting | 9903 | €-7,78M |
| Belastingen op het resultaat | 67/77 | €3 |
| Resultaat van het boekjaar | 9904 | €-7,78M |
| Te bestemmen resultaat | 9905 | €-7,78M |
-
Biotech corporate devRechtspersoonGedelegeerd bestuurder· vast vert.: Frédéric LegrosStaatsblad-akte 24448711 (05-12-2024)Actief05-12-2024 → heden
-
Criteria Bio Ventures SICC SARechtspersoonGedelegeerd bestuurder· vast vert.: Pablo Cironi LópezStaatsblad-akte 24448711 (05-12-2024)Actief05-12-2024 → heden
-
Sound Bioventures Management ABRechtspersoonGedelegeerd bestuurder· vast vert.: Bibhash MukhopadhyayStaatsblad-akte 24448711 (05-12-2024)Actief05-12-2024 → heden
Voormalige bestuurders (2)
-
Bibhash MukhopadhyayGedelegeerd bestuurderStaatsblad-akte 24448711 (05-12-2024)Voormalig- → 05-12-2024
-
Pablo Cironi LópezGedelegeerd bestuurderStaatsblad-akte 24448711 (05-12-2024)Voormalig- → 05-12-2024
| NACE primair | 72101 |
| Rechtsvorm | NV(014) |
| Oprichtingsdatum | 27-06-2023 |
| Status | Actief |
| Postcode | 6041 |
Percelen gekoppeld aan dit bedrijf via zijn adressen in de KBO (zetel, vestigingen, bijkantoren), gekruist met het kadastraal percelenplan. Dit toont waar het bedrijf actief is, geen eigendomsregister.
| Perceel (capakey) | Regio | Oppervlakte | Gebouwen | Hoogte / verd. |
|---|---|---|---|---|
| 52028B0323/00M003 | Wallonië | 8.679 m² | 1 · 791 m² | 18,8 m · 5 verd. |
Eén tijdlijn van alles wat er met dit bedrijf is gebeurd, publicaties, insolventie- en levensloopgebeurtenissen, administratieve wijzigingen en neergelegde jaarrekeningen.
16-09-2025 3 bestuurders benoemd
- Laurent Verhavert, Directeur
- Simon Bizimana, Directeur
- Strelia, Directeur
Technische details
{
"events": [
{
"kind": "rep_rotation",
"role": "directeur",
"person": {
"rrn": null,
"name": "Guillaume Heynen",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": null,
"via_org": {
"kbo": null,
"name": "Newton Biocapital Partners",
"address": null,
"country": null,
"legal_form": null
},
"statutory": null,
"compensated": null,
"effective_date": null,
"evidence_quote": "Les administrateurs prennent acte du remplacement de Mr. Guillaume Heynen par Mr. Alain Parthoens comme repr\u00E9sentant permanent de l\u0027administrateur Newton Biocapital Partners.",
"decharge_status": null,
"mandate_duration": null,
"rep_rotation_new_rep": "Alain Parthoens",
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "rep_rotation",
"role": "directeur",
"person": {
"rrn": null,
"name": "Bibhash Mukhopadhyay",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": null,
"via_org": {
"kbo": null,
"name": "Sound Bioventures Management AB",
"address": null,
"country": null,
"legal_form": null
},
"statutory": null,
"compensated": null,
"effective_date": null,
"evidence_quote": "Les administrateurs prennent acte du remplacement de Mr. Bibhash Mukhopadhyay par Mr. Casper Breum comme repr\u00E9sentant permanent de l\u0027administrateur Sound Bioventures Management A\u0412.",
"decharge_status": null,
"mandate_duration": null,
"rep_rotation_new_rep": "Casper Breum",
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "delegation_dagelijks_bestuur_in",
"role": "directeur",
"person": {
"rrn": null,
"name": "Laurent Verhavert",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": null,
"via_org": null,
"statutory": null,
"compensated": null,
"effective_date": null,
"evidence_quote": "Les administrateurs donnent procuration \u00E0 Laurent Verhavert, Simon Bizimana et tout autre avocat ou employ\u00E9 du cabinet Strelia ayant tous leurs bureaux situ\u00E9s rue de la R\u00E9gence 52, 1000 Bruxelles, chacun agissant individuellement et avec pouvoir de substitution, afin d\u0027accomplir toutes les formalit\u00E9",
"decharge_status": null,
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "delegation_dagelijks_bestuur_in",
"role": "directeur",
"person": {
"rrn": null,
"name": "Simon Bizimana",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": null,
"via_org": null,
"statutory": null,
"compensated": null,
"effective_date": null,
"evidence_quote": "Les administrateurs donnent procuration \u00E0 Laurent Verhavert, Simon Bizimana et tout autre avocat ou employ\u00E9 du cabinet Strelia ayant tous leurs bureaux situ\u00E9s rue de la R\u00E9gence 52, 1000 Bruxelles, chacun agissant individuellement et avec pouvoir de substitution, afin d\u0027accomplir toutes les formalit\u00E9",
"decharge_status": null,
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "delegation_dagelijks_bestuur_in",
"role": "directeur",
"person": null,
"reason": null,
"subkind": null,
"via_org": {
"kbo": null,
"name": "Strelia",
"address": "rue de la R\u00E9gence 52, 1000 Bruxelles",
"country": "BE",
"legal_form": null
},
"statutory": null,
"compensated": null,
"effective_date": null,
"evidence_quote": "Les administrateurs donnent procuration \u00E0 Laurent Verhavert, Simon Bizimana et tout autre avocat ou employ\u00E9 du cabinet Strelia ayant tous leurs bureaux situ\u00E9s rue de la R\u00E9gence 52, 1000 Bruxelles, chacun agissant individuellement et avec pouvoir de substitution, afin d\u0027accomplir toutes les formalit\u00E9",
"decharge_status": null,
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
}
],
"notary": {
"name": null,
"firm_city": null,
"firm_name": null,
"office_city": null,
"is_associated": false
},
"act_meta": {
"language": "mixed",
"pub_date": "2025-09-16",
"filing_date": "2025-09-08",
"act_kind_objet": "Objet de l\u0027acte:"
},
"decisions": [
{
"body": "enig_aandeelhouder_schriftelijk",
"date": "2025-06-10",
"unanimous": null
}
],
"is_correction": false,
"subject_company": {
"kbo": "0803.217.012",
"name_full": "ABOLERIS HOLDCO",
"legal_form": "SA"
},
"publication_proxy": {
"kind": "org",
"org_kbo": null,
"org_name": "Strelia",
"person_name": null,
"org_rep_person_name": "Simon Bizimana",
"person_role_at_subject": null
},
"co_filed_documents": [],
"corrected_publication_numac": null
}14-04-2025 Kapitaalverhoging van €7.499.508 tot €30.988.985
- €23.489.477 → €30.988.985
Technische details
{
"events": [
{
"kind": "capital_increase",
"after_eur": 30988985.0,
"delta_eur": 7499508.0,
"before_eur": 23489477.0,
"share_emission": {
"agio_eur": 7499508.0,
"share_form": "no_nominal_value",
"share_class": "A",
"n_new_shares": 53188,
"with_new_shares": true,
"nominal_value_eur": null,
"issue_price_per_share_eur": 141.0
},
"decrease_purpose": null,
"contribution_type": "numeraire",
"paid_up_delta_eur": 7499508.0,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
}
],
"notary": {
"name": "Peter VAN MELKEBEKE",
"firm_city": null,
"firm_name": "BERQUIN NOTAIRES",
"office_city": "Bruxelles",
"is_associated": true
},
"act_meta": {
"language": "fr",
"pub_date": "2025-04-14",
"filing_date": "2025-04-10",
"act_kind_objet": "Objet de l\u0027acte:"
},
"decision": {
"body": "assembl\u00E9e_generale_extraordinaire",
"act_date": "2025-04-02",
"unanimous": null,
"under_authorized_capital": false,
"underlying_resolution_date": null
},
"bedrijfsrevisor": null,
"subject_company": {
"kbo": "0803.217.012",
"name_full": "Aboleris Holdco",
"legal_form": "Soci\u00E9t\u00E9 anonyme",
"is_foreign_registered": false
},
"publication_proxy": {
"kind": "none",
"org_kbo": null,
"org_name": null,
"person_name": null,
"org_rep_person_name": null,
"person_role_at_subject": null
},
"co_filed_documents": [
"exp\u00E9dition du proc\u00E8s-verbal",
"liste de pr\u00E9sence",
"neuf procurations",
"le rapport de l\u0027organe d\u0027administration",
"le rapport du commissaire \u00E9valuant",
"le texte coordonn\u00E9 des statuts"
],
"shareholders_after": [],
"share_classes_after": [
{
"n_shares": 20000,
"class_name": "Ordinaires",
"capital_share_eur": null,
"voting_rights_per_share": 1.0
},
{
"n_shares": 22500,
"class_name": "Seed A",
"capital_share_eur": null,
"voting_rights_per_share": 1.0
},
{
"n_shares": 1263,
"class_name": "Seed A\u0027",
"capital_share_eur": null,
"voting_rights_per_share": 1.0
},
{
"n_shares": 151866,
"class_name": "Pr\u00E9f\u00E9rentielles A",
"capital_share_eur": null,
"voting_rights_per_share": 1.0
}
]
}05-12-2024 Publicatie in het Belgisch Staatsblad, Diversen
Technische details
{
"stage": null,
"notary": {
"name": "Kim Lagae",
"firm_city": null,
"firm_name": null,
"office_city": null,
"is_associated": false
},
"act_meta": {
"language": "mixed",
"pub_date": "2024-12-05",
"filing_date": "2024-12-03",
"act_kind_objet": "DEMISSIONS, NOMINATIONS, DIVERS"
},
"decision": {
"body": "enig_aandeelhouder_schriftelijk",
"act_date": "2024-01-22",
"unanimous": true
},
"conversion": null,
"detected_kind": "other",
"report_waiver": null,
"restructuring": {
"parties": [
{
"kbo": "0803.217.012",
"name": "Aboleris Holdco",
"role": "other",
"address": "Rue Antoine de Saint-Exup\u00E9ry 14, 6041 Charleroi",
"is_foreign": false,
"legal_form": "Soci\u00E9t\u00E9 anonyme",
"is_new_company": false,
"jurisdiction_country": null
},
{
"kbo": "0803.336.281",
"name": "Criteria Bio Ventures SICC SA",
"role": "contributor",
"address": null,
"is_foreign": true,
"legal_form": "SA",
"is_new_company": false,
"jurisdiction_country": "ES"
},
{
"kbo": null,
"name": "Sound Bioventures Management AB",
"role": "contributor",
"address": null,
"is_foreign": true,
"legal_form": "AB",
"is_new_company": false,
"jurisdiction_country": "SE"
},
{
"kbo": null,
"name": "Biotech corporate dev",
"role": "contributor",
"address": "35 quai Jean Pierre Fougerat, 44220 Coueron",
"is_foreign": true,
"legal_form": null,
"is_new_company": false,
"jurisdiction_country": "FR"
}
],
"exchange_ratio": null,
"legal_articles": [
"7:133"
],
"is_cross_border": true,
"is_silent_merger": false,
"balance_basis_date": null,
"exchange_ratio_text": null,
"new_shares_issued_n": null,
"real_estate_included": false,
"patrimony_description": null,
"equity_transferred_eur": null,
"accounting_effective_date": null
},
"subject_company": {
"kbo": "0803.217.012",
"name_full": "Aboleris Holdco",
"legal_form": "Soci\u00E9t\u00E9 anonyme"
},
"publication_proxy": {
"kind": "org",
"org_kbo": null,
"org_name": null,
"person_name": null,
"org_rep_person_name": null
},
"summary_narrative": "L\u0027assembl\u00E9e g\u00E9n\u00E9rale a pris acte de la d\u00E9mission de deux administrateurs et a nomm\u00E9 trois nouveaux administrateurs, dont deux soci\u00E9t\u00E9s \u00E9trang\u00E8res et une soci\u00E9t\u00E9 fran\u00E7aise, pour une dur\u00E9e de six ans.",
"co_filed_documents": [
"une copie des d\u00E9cisions \u00E9crites"
],
"detected_real_type": "other",
"referenced_correction": null,
"should_reroute_to_category": "director_changes"
}25-04-2024 Kapitaalverhoging van €7.900.000 tot €23.489.477
- €15.589.477 → €23.489.477
- Inbreng in geld · Apport en numéraire
Technische details
{
"events": [
{
"kind": "capital_increase",
"after_eur": 23489477.0,
"delta_eur": 7900000.0,
"before_eur": 15589477.0,
"share_emission": {
"agio_eur": null,
"share_form": "nominal",
"share_class": "A",
"n_new_shares": 63198,
"with_new_shares": true,
"nominal_value_eur": null,
"issue_price_per_share_eur": null
},
"decrease_purpose": null,
"contribution_type": "geld",
"paid_up_delta_eur": 7900000.0,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "share_class_creation",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"share_emission": {
"agio_eur": null,
"share_form": null,
"share_class": null,
"n_new_shares": null,
"with_new_shares": false,
"nominal_value_eur": null,
"issue_price_per_share_eur": null
},
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "warrant_issuance",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"share_emission": {
"agio_eur": null,
"share_form": null,
"share_class": null,
"n_new_shares": null,
"with_new_shares": false,
"nominal_value_eur": null,
"issue_price_per_share_eur": null
},
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "warrant_issuance",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"share_emission": {
"agio_eur": null,
"share_form": null,
"share_class": null,
"n_new_shares": null,
"with_new_shares": false,
"nominal_value_eur": null,
"issue_price_per_share_eur": null
},
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "warrant_issuance",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"share_emission": {
"agio_eur": null,
"share_form": null,
"share_class": null,
"n_new_shares": null,
"with_new_shares": false,
"nominal_value_eur": null,
"issue_price_per_share_eur": null
},
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
}
],
"notary": {
"name": "Kim LAGAE",
"firm_city": null,
"firm_name": null,
"office_city": "Bruxelles",
"is_associated": false
},
"act_meta": {
"language": "mixed",
"pub_date": "2024-04-25",
"filing_date": "2024-04-23",
"act_kind_objet": "Objet de l\u0027acte:"
},
"decision": {
"body": "assembl\u00E9e g\u00E9n\u00E9rale extraor-dinaire des actionnaires",
"act_date": "2024-04-17",
"unanimous": null,
"under_authorized_capital": false,
"underlying_resolution_date": null
},
"bedrijfsrevisor": null,
"subject_company": {
"kbo": "0803.217.012",
"name_full": "Aboleris Holdco",
"legal_form": "Soci\u00E9t\u00E9 anonyme",
"is_foreign_registered": false
},
"publication_proxy": {
"kind": "none",
"org_kbo": null,
"org_name": null,
"person_name": null,
"org_rep_person_name": null,
"person_role_at_subject": null
},
"co_filed_documents": [
"expedition conforme de l\u0027acte",
"procurations",
"Rapport sp\u00E9cial du conseil d\u0027administration",
"Rapport sp\u00E9cial du commissaire",
"coordination des statuts"
],
"shareholders_after": [],
"share_classes_after": [
{
"n_shares": 20000,
"class_name": "Ordinaires",
"capital_share_eur": null,
"voting_rights_per_share": 1.0
},
{
"n_shares": 22500,
"class_name": "Seed A",
"capital_share_eur": null,
"voting_rights_per_share": 1.0
},
{
"n_shares": 1263,
"class_name": "Seed A\u0027",
"capital_share_eur": null,
"voting_rights_per_share": 1.0
},
{
"n_shares": 98678,
"class_name": "Pr\u00E9f\u00E9rentielles A",
"capital_share_eur": null,
"voting_rights_per_share": 1.0
}
]
}16-04-2024 Zetelverplaatsing naar Gosselies
- rue Antoine Saint-Exupéry 14 à 6041 Gosselies
Technische details
{
"events": [
{
"kind": "zetel_transfer",
"seat_type": "siege_social",
"new_address": {
"raw": "rue Antoine Saint-Exup\u00E9ry 14 \u00E0 6041 Gosselies",
"city": "Gosselies",
"region": "waals_gewest",
"street": "Antoine Saint-Exup\u00E9ry",
"country": "BE",
"postcode": "6041",
"box_number": null,
"street_number": "14",
"locality_suffix": null
},
"old_address": null,
"effective_date": "2024-05-01",
"evidence_quote": "",
"region_changed": false,
"is_statute_change": true,
"nationality_change": false,
"old_address_source": "missing",
"statute_clause_text": null,
"statute_article_number": null,
"effective_date_qualifier": "future",
"statutaire_vs_werkelijke": "statutaire",
"linguistic_region_changed": false,
"court_jurisdiction_changed": false,
"effective_date_is_approximate": false
}
],
"notary": {
"name": null,
"firm_city": null,
"firm_name": null,
"office_city": null,
"is_associated": false
},
"act_meta": {
"language": "mixed",
"pub_date": "2024-04-16",
"filing_date": null,
"act_kind_objet": "Objet de l\u0027acte:"
},
"decision": {
"body": "algemene_vergadering",
"date": "2024-04-05",
"unanimous": null
},
"subject_company": {
"kbo": "0803.217.012",
"name_full": "ABOLERIS HOLDO",
"legal_form": "SA"
},
"publication_proxy": {
"kind": "org",
"org_kbo": null,
"org_name": "BDO R\u00E9viseurs d\u0027Entreprises SRL",
"person_name": null,
"org_rep_person_name": "S\u00E9bastien Jaspar",
"person_role_at_subject": null
},
"co_filed_documents": [
"Bijlagen bij bij het het Belgisch Staatsblad",
"Annexes du Moniteur belge"
]
}20-07-2023 Kapitaalverhoging van €6.150.000 tot €15.589.477
- €9.439.477 → €15.589.477
- Inbreng in geld · Apport en numéraire
- 2 kapitaalbewegingen in deze akte
Technische details
{
"events": [
{
"kind": "eenhoofdigheid_declaration",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "share_class_creation",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "statutory_reserve_release",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "capital_increase",
"after_eur": 9439477.0,
"delta_eur": 720000.0,
"before_eur": 8719477.0,
"subscribers": [
{
"kbo": null,
"rrn": null,
"kind": "org",
"name": "Newton Biocapital I",
"share_class": "A",
"liberation_pct": 100.0,
"contribution_kind": "schuldvordering",
"n_shares_subscribed": 2880,
"contribution_amount_eur": 720000.0
}
],
"share_emission": {
"agio_eur": null,
"share_form": "pair_comptable",
"share_class": "A",
"n_new_shares": 2880,
"with_new_shares": true,
"nominal_value_eur": null,
"issue_price_per_share_eur": null
},
"decrease_purpose": null,
"contribution_type": "inschrijvingsrechten_uitgifte",
"paid_up_delta_eur": 720000.0,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "capital_increase",
"after_eur": 15589477.0,
"delta_eur": 6150000.0,
"before_eur": 9439477.0,
"share_emission": {
"agio_eur": null,
"share_form": "pair_comptable",
"share_class": "A",
"n_new_shares": 24600,
"with_new_shares": true,
"nominal_value_eur": null,
"issue_price_per_share_eur": 250.0
},
"decrease_purpose": null,
"contribution_type": "geld",
"paid_up_delta_eur": 6150000.0,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "warrant_issuance",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "warrant_issuance",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "warrant_issuance",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
}
],
"notary": {
"name": "Kim LAGAE",
"firm_city": null,
"firm_name": null,
"office_city": "Bruxelles",
"is_associated": false
},
"act_meta": {
"language": "fr",
"pub_date": "2023-07-20",
"filing_date": "2023-07-18",
"act_kind_objet": "Objet de l\u0027acte:"
},
"decision": {
"body": "assembl\u00E9e g\u00E9n\u00E9rale extraordinaire",
"act_date": "2023-07-10",
"unanimous": null,
"under_authorized_capital": false,
"underlying_resolution_date": null
},
"bedrijfsrevisor": {
"waived": false,
"firm_kbo": null,
"firm_name": "CdP NB\u0026C\u00B0 SRL, R\u00E9viseurs d\u2019entreprises",
"ibr_number": null,
"mission_type": "apport_nature",
"individual_name": "Jean Nicolet"
},
"subject_company": {
"kbo": "0803.217.012",
"name_full": "Aboleris Holdco",
"legal_form": "Soci\u00E9t\u00E9 anonyme",
"is_foreign_registered": false
},
"publication_proxy": {
"kind": "none",
"org_kbo": null,
"org_name": null,
"person_name": null,
"org_rep_person_name": null,
"person_role_at_subject": null
},
"co_filed_documents": [
"expedition",
"rapports",
"coordination des statuts"
],
"shareholders_after": [],
"share_classes_after": [
{
"n_shares": 27440,
"class_name": "Actions Pr\u00E9f\u00E9rentielles A",
"capital_share_eur": 9439477.0,
"voting_rights_per_share": 1.0
}
]
}12-07-2023 Kapitaalverhoging van €5.519.264,03 tot €8.719.477
- €3.200.212,97 → €8.719.477
Technische details
{
"events": [
{
"kind": "capital_increase",
"after_eur": 8719477.0,
"delta_eur": 5519264.03,
"before_eur": 3200212.97,
"subscribers": [
{
"kbo": null,
"rrn": null,
"kind": "org",
"name": "Investisseurs d\u2019actions de la soci\u00E9t\u00E9 Aboleris Pharma",
"share_class": null,
"liberation_pct": 100.0,
"contribution_kind": "natura",
"n_shares_subscribed": 32765,
"contribution_amount_eur": 5519264.03
}
],
"share_emission": {
"agio_eur": null,
"share_form": "pair_comptable",
"share_class": null,
"n_new_shares": 32765,
"with_new_shares": true,
"nominal_value_eur": null,
"issue_price_per_share_eur": null
},
"decrease_purpose": null,
"contribution_type": "apport_nature",
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "share_class_creation",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"share_emission": {
"agio_eur": null,
"share_form": null,
"share_class": null,
"n_new_shares": null,
"with_new_shares": false,
"nominal_value_eur": null,
"issue_price_per_share_eur": null
},
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
}
],
"notary": {
"name": "Kim LAGAE",
"firm_city": null,
"firm_name": null,
"office_city": "Bruxelles",
"is_associated": false
},
"act_meta": {
"language": "fr",
"pub_date": "2023-07-12",
"filing_date": "2023-07-10",
"act_kind_objet": "Objet de l\u0027acte:"
},
"decision": {
"body": "assembl\u00E9e_generale_extraordinaire",
"act_date": null,
"unanimous": null,
"under_authorized_capital": false,
"underlying_resolution_date": null
},
"bedrijfsrevisor": {
"waived": false,
"firm_kbo": null,
"firm_name": "CDP NICOLET, BERTRAND \u0026 C\u00B0 R\u00E9viseurs d\u2019entreprises SRL",
"ibr_number": null,
"mission_type": "apport_nature",
"individual_name": "Jean NICOLET"
},
"subject_company": {
"kbo": "0803.217.012",
"name_full": "Aboleris Holdco",
"legal_form": "Soci\u00E9t\u00E9 anonyme",
"is_foreign_registered": false
},
"publication_proxy": {
"kind": "none",
"org_kbo": null,
"org_name": null,
"person_name": null,
"org_rep_person_name": null,
"person_role_at_subject": null
},
"co_filed_documents": [
"exp\u00E9dition conforme de l\u2019acte",
"procurations",
"coordination des statuts"
],
"shareholders_after": [],
"share_classes_after": [
{
"n_shares": 51763,
"class_name": "Gewone Aandelen",
"capital_share_eur": 8719477.0,
"voting_rights_per_share": 1.0
}
]
}Genereer een gestructureerde, feitelijke nota op basis van alle signalen in dit dossier: risico, financiële gezondheid, eigendomsstructuur, mandaten en sectorvergelijking.
| Officiële naamFR | Aboleris Holdco |